ASGN (Everforth) Q2 Beat: Revenue Tops $1B, EBITDA Margin 9.6%

What happened

Transitioning under the Everforth name, ASGN delivered Q2 2026 revenue above $1 billion and adjusted EBITDA margin of 9.6%, both surpassing the high end of management’s guidance range. The top‑line beat underscores resilience in its federal segment and potential stabilization in commercial assignments, though the master report’s caution on cyclical softness and negative interest coverage remains relevant. With the $3.1 billion federal backlog still an anchor, the margin expansion signals improved operating leverage. However, the lofty EV/EBITDA of 68.1x and the still‑unresolved debt coverage ratios temper enthusiasm, as the market has yet to fully price in a sustainable recovery. The name change to Everforth appears cosmetic, with no announced structural shift, leaving the investment thesis largely intact but with a slightly brighter near‑term trajectory.

Implication

ASGN’s Q2 beat confirms operational momentum, yet the 68.1x EV/EBITDA multiple and negative interest coverage highlight persistent overvaluation and balance‑sheet risks. Investors should monitor next quarter’s commercial assignment revenue and federal conversion to see if margin gains are durable. A sustained beat could justify a BUY, but any miss might trigger a sell‑off given high expectations. The name change to Everforth is a non‑event; focus remains on fundamental improvement. Maintain HOLD until we see at least two quarters of positive coverage and commercial stabilization.

Thesis delta

The Q2 top- and bottom-line beat nudges the thesis toward cautious optimism but does not alter the HOLD rating. While execution appears strong, the company must still prove it can convert backlog and improve interest coverage. Any sign of commercial recovery would be a catalyst, but for now, the beat is a single quarter’s data.